Skip to main content

View full-text article in PMC

. 2022 Aug 5;10(8):1893. doi: 10.3390/biomedicines10081893

Table 1.

Statistically significant correlations between PD-L1 and pS6 expression among time points of evaluation.

Phenotypes (Time Points)		p
CK⁺PD-L1⁺CD45⁻ (B)	CK⁺pS6⁺ (B)	<0.001
CK⁺PD-L1⁺CD45⁻ (B)	CK^lowpS6⁺ (B)	0.035
CK^lowPD-L1⁺CD45⁻ (B)	CK^lowpS6⁺ (B)	0.011
CK⁺PD-L1⁺CD45⁻ (P 1st)	CK⁺pS6⁺ (P 1st)	0.004
CK⁺PD-L1⁺CD45⁻ (P 1st)	CK^lowpS6⁺ (P 1st)	0.010
CK⁺PD-L1⁺CD45⁻ (EOT)	CK⁺pS6⁺ (EOT)	<0.001
CK⁺PD-L1⁺CD45⁻ (EOT)	CK^lowpS6⁺ (EOT)	0.039
CK^lowPD-L1⁺CD45⁻ (EOT)	CK^lowpS6⁺ (EOT)	0.030

B, baseline; P 1st, post 1st cycle; EOT, end of treatment.